Table 1. Patient and donor... | American Society of Hematology

Table 1.

Patient and donor characteristics

	Donor/patient sex
	F/F	M/F	F/M	M/M
No.	646	586	858	1148
Median patient age, y (range)	33 (1-72)	32 (1-64)	32 (1-68)	33 (1-68)
Median donor age, y (range)	33 (1-78)	32 (1-68)	32 (1-70)	32 (1-72)
Disease
CML	170	134	239	319
AML	232	219	240	332
ALL	121	93	186	205
Myelodysplastic syndrome	44	44	61	89
Hodgkin disease	15	7	21	25
Multiple myeloma	20	26	19	47
Non-Hodgkin lymphoma	37	54	68	106
Other	7	9	24	25
Disease status
Less advanced	335	300	414	546
More advanced	311	286	444	602
GVHD prophylaxis
CSP/MTX	284	284	411	486
Other	362	302	447	662
Conditioning regimen
TBI containing	489	439	610	859
Non-TBI containing	157	147	248	289
Patient CMV serostatus
Positive	269	276	283	379
Negative	197	208	319	401
Unknown	180	102	256	367
Donor CMV serostatus
Positive	264	198	308	345
Negative	222	285	304	446
Unknown	160	103	246	357

	Donor/patient sex
	F/F	M/F	F/M	M/M
No.	646	586	858	1148
Median patient age, y (range)	33 (1-72)	32 (1-64)	32 (1-68)	33 (1-68)
Median donor age, y (range)	33 (1-78)	32 (1-68)	32 (1-70)	32 (1-72)
Disease
CML	170	134	239	319
AML	232	219	240	332
ALL	121	93	186	205
Myelodysplastic syndrome	44	44	61	89
Hodgkin disease	15	7	21	25
Multiple myeloma	20	26	19	47
Non-Hodgkin lymphoma	37	54	68	106
Other	7	9	24	25
Disease status
Less advanced	335	300	414	546
More advanced	311	286	444	602
GVHD prophylaxis
CSP/MTX	284	284	411	486
Other	362	302	447	662
Conditioning regimen
TBI containing	489	439	610	859
Non-TBI containing	157	147	248	289
Patient CMV serostatus
Positive	269	276	283	379
Negative	197	208	319	401
Unknown	180	102	256	367
Donor CMV serostatus
Positive	264	198	308	345
Negative	222	285	304	446
Unknown	160	103	246	357

All patients received HSC transplants at the FHCRC from HLA-identical siblings between 1969 and 2001.

CSP indicates cyclosporine; MTX, methotrexate; TBI, total body irradiation; and CMV, cytomegalovirus.